Funders · Entity Annotation Prototype (beta)

90articles mentioning funders

224funder mentions

1distinct funders extracted

0%of mentions human-reviewed

Active filtersEntity: FDA ×

FDA

This funder is selected. Its supporting articles are shown below.

FDA90

Articles mentioning FDA

90 articles · page 1 of 8

Costs and benefits of early access to new cancer drugs through the US Food and Drug Administration’s accelerated approval pathway: retrospective observational study and economic evaluation

bmjmed · full text · 2025-12-16 · 82 matching annotations

94.6%

Medicare

…approval pathway accounted for an estimated $20bn in additional Medicare spending, but most beneficiaries derived minimal or no survival…

Communicating clinical trial information about cancer drug products to patients and healthcare professionals: review of patient-reported outcome messaging

bmjonc · full text · 2026-04-07 · 12 matching annotations

86.8%

FDA EMA FDA ESMO ASCO

…Zykadia), ramucirumab (Cyramza), and nintedanib (Vargatef); the FDA also granted a claim to ceritinib (Zykadia). Limited HCP-facing…

Costs and benefits of early access to new cancer drugs through the US Food and Drug Administration’s accelerated approval pathway: retrospective observational study and economic evaluation

bmjmed · abstract · 2025-12-16 · 10 matching annotations

87.0%

FDA Medicare US Food and Drug Administration

…associated with cancer drug indications that initially received FDA accelerated approval. Each indications’s overall survival benef…

Current and emerging therapies for pulmonary tuberculosis in adults

bmjmed · full text · 2026-04-22 · 6 matching annotations

83.7%

World Health Organization WHO

…iline 2012: US Food and Drug Administration (FDA) approval2013: World Health Organization (WHO) recommendation2014: European Medicines Agency (EMA) appro…

Bladder-sparing strategies for non-muscle-invasive bladder cancer after bacillus Calmette–Guérin failure: a systematic review

bmjonc · full text · 2026-02-01 · 6 matching annotations

82.6%

FDA Alliance for Clinical Trials in Oncology

…n launched and their outcomes are awaited. As of June 2025, the FDA has approved valrubicin, pembrolizumab, nadofaragene firadenove…

Metabolic dysfunction associated steatotic liver disease: mechanisms, diagnosis, and management in adults

bmjmed · full text · 2026-03-31 · 4 matching annotations

90.9%

NCT05809934 FDA National Institute for Care and Excellence AASLD National Institute of Care and Excellence NCT04822181 American Association for the Study of Liver Diseases

…ently underway and is expected to be completed in October 2025 (NCT05809934).In summary, the therapeutic landscape for MASLD and MASH is ra…

Qualitative study of oncologists’ perceptions on the US Food and Drug Administration approval status and clinical practice guidelines and their impact on local practice patterns in India

bmjonc · abstract · 2025-10-22 · 4 matching annotations

82.5%

US Food and Drug Administration FDA cancer drugs NCCN guidelines

…Objective How the US Food and Drug Administration (FDA) approval status and international cancer care guidelines …

TAAT hemp cigarettes’ unsubstantiated cessation and harm reduction claims

tobaccocontrol · abstract · 2025-12-03 · 3 matching annotations

84.9%

FDA US Food and Drug Administration Federal Trade Commission nicotine

…Introduction The US Food and Drug Administration (FDA) has the authority to prohibit companies from making unauthoris…

P.149 Don’t count your chickens before they hatch! Analysis of cardiovascular definitions in studies on systemic sclerosis: a systematic literature review

jsrd · abstract · 2026-06-05 · 2 matching annotations

89.8%

FDA FDA WHO rheumatoid arthritis systemic sclerosis WHO Cochrane Central Library PubMed Embase RA+1 more

…2 were conducted on SSc, 4 studies investigated both diseases. ‘FDA MACE’ definition was employed in 46 papers on RA (13%) and 2 pa…

Modified risk tobacco product (MRTP) claim, nicotine strength and nicotine label on ZYN perceptions and use intentions among adults who are currently smoking cigarettes

tobaccocontrol · abstract · 2026-04-03 · 2 matching annotations

90.9%

FDA Swedish Match USA U.S. Food and Drug Administration ZYN

…kground On 17 June 2025, the U.S. Food and Drug Administration (FDA) filed a scientific review for modified risk tobacco product (M…

Real-world safety assessment of avacopan in patients with antineutrophil cytoplasmic antibody-associated vasculitis

rmdopen · abstract · 2026-03-25 · 2 matching annotations

87.2%

Food and Drug Administration FDA avacopan avacopan-related antineutrophil cytoplasmic antibody-associated vasculitis

…Objective Postmarketing safety data of avacopan, the first Food and Drug Administration (FDA) approved drug in a decade for antineutrophil cytoplasmic …

Postmarketing safety surveillance for GSK’s AS01E-adjuvanted respiratory syncytial virus prefusion F protein-based vaccine in the USA: protocol for a non-interventional postauthorisation safety study

bmjopen · abstract · 2026-03-19 · 2 matching annotations

84.6%

FDA US Food and Drug Administration atrial fibrillation Harvard Pilgrim Health Care Institute Guillain-Barré syndrome acute disseminated encephalomyelitis GBS ADEM RSV-associated lower respiratory tract disease WIRB-Copernicus Group, Inc+2 more

…Introduction In May 2023, the US Food and Drug Administration (FDA) initially approved an AS01 E-adjuvanted respiratory syncytial …

Browse funders

FDA

Articles mentioning FDA